# TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size

**Authors:** Khader Ghneim, Felipe ten-Caten, Ana Carolina Santana, Muhammad Bilal Latif, Diego Andres Diaz Dinamarca, Tamara García-Salum, Perla Mariana Del Rio Estrada, Puja Sohal, Zachary Strongin, Justin Harper, Sherrie Jean, Chelsea Wallace, Robert Balderas, Jeffrey D Lifson, Gopalan Raghunathan, Eric Rimmer, Cinthia Pastuskova, Guoxin Wu, Luca Micci, Luiz Felipe Martins Sieben, Pedro Cesar Lopes Gerum, Jessica dos Santos, Mihai G Netea, Andre van der Ven, Guido Silvestri, Daria J Hazuda, Daniel M Gorman, Bonnie J Howell, Ashish A Sharma, Mirko Paiardini, Hugo Soudeyns, Susan Pereira Ribeiro, Rafick P Sekaly

PMC · DOI: 10.21203/rs.3.rs-5626892/v1 · 2025-03-19

## TL;DR

This study shows how TGF-β affects the epigenetic control of antiviral responses in innate immune cells, influencing the size of the SIV reservoir in rhesus macaques.

## Contribution

The paper identifies a novel molecular cascade involving TGF-β and epigenetic regulation that controls antiviral immunity and viral reservoirs.

## Key findings

- TGF-β/SMAD signaling suppressed antiviral activity through HDAC11 in some treated rhesus macaques.
- HDAC inhibitors restored antiviral responses in the presence of TGF-β in vitro.
- A similar molecular cascade was observed in HIV elite controllers with low viral reservoirs.

## Abstract

Immunotherapeutic approaches to eliminate latently HIV-infected cells are focused on the adaptive immune system. Herein we provide mechanistic evidence for a molecular cascade characterized by epigenetic reprogramming of innate myeloid cells and CD4 T cells. The coordinate regulation and gene expression mediated by transcription factors (TFs) IRF3, IRF7, STAT1 and C/EBPβ versus AP-1, promoted the development of innate antiviral immunity in these cells which was associated with control of viral load and decay of cell associated viral DNA (CA-vDNA) following analytical treatment interruption (ATI) in SIV-infected rhesus macaques (RMs) treated with anti-IL-10 and anti-PD-1. The prevalence of TGF-β/SMAD signaling in a subset of combo-treated RMs with high CA-vDNA (CA-vDNAhi) suppressed this antiviral activity through histone deacetylases, including HDAC11, as the latter reduced chromatin accessibility of IRFs and STATs and impeded their antiviral functions. The addition of HDAC inhibitors in vitro restored antiviral response in the presence of TGF-β. Induction of IL-6, a target gene of C/EBPβ, in CA-vDNAlo RMs, amplified the antiviral network through IRF9, a transcription factor upstream of IRF7. We identified a similar molecular cascade in HIV elite controllers, who maintain low to undetectable viremia and small viral reservoirs without treatment. These data highlight the importance of epigenetic regulation of the host in shaping innate antiviral immune responses that control viral rebound following ATI and reduce the viral reservoir, providing insight into potential strategies for HIV cure interventions.

## Linked entities

- **Genes:** IRF3 (interferon regulatory factor 3) [NCBI Gene 3661], IRF7 (interferon regulatory factor 7) [NCBI Gene 3665], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772], CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051], FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353], HDAC11 (histone deacetylase 11) [NCBI Gene 79885], IRF9 (interferon regulatory factor 9) [NCBI Gene 10379]
- **Proteins:** TGFB1 (transforming growth factor beta 1), Smox (Smad on X), HDAC11 (histone deacetylase 11), IRF3 (interferon regulatory factor 3), IRF7 (interferon regulatory factor 7), STAT1 (signal transducer and activator of transcription 1), CEBPB (CCAAT enhancer binding protein beta), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IRF9 (interferon regulatory factor 9)
- **Diseases:** SIV (MONDO:0700112)

## Full-text entities

- **Genes:** TGF-beta [NCBI Gene 574135], CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 713191], IL6 (interleukin 6) [NCBI Gene 705819], IL10 (interleukin 10) [NCBI Gene 694931] {aka IF2A}, IRF7 (interferon regulatory factor 7) [NCBI Gene 699578], IRF3 (interferon regulatory factor 3) [NCBI Gene 718970], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 693650], CD4 (CD4 molecule) [NCBI Gene 713807], PDCD1 (programmed cell death 1) [NCBI Gene 100135775] {aka PD1}, IRF9 (interferon regulatory factor 9) [NCBI Gene 715335], HDAC11 (histone deacetylase 11) [NCBI Gene 693537]
- **Diseases:** SIV-infected (OMIM:270100), HIV (MESH:D015658), viremia (MESH:D014766)
- **Chemicals:** CA (MESH:D002118)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Qubevirus faecium (species) [taxon 39804], Macaca mulatta (rhesus macaque, species) [taxon 9544]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11957188/full.md

---
Source: https://tomesphere.com/paper/PMC11957188